PQQ Supplement Review: How It Compares to Proven Nootropics in 2026

PQQ (pyrroloquinoline quinone) has become one of the most talked-about compounds in the supplement world — marketed as a mitochondrial miracle that may boost energy, sharpen cognition, and slow ageing. But when you score the actual human evidence for a PQQ supplement against well-studied nootropics like citicoline, rhodiola rosea, and phosphatidylserine using the same three-tier evidence hierarchy — cell studies, animal models, and replicated human RCTs — a much more nuanced picture emerges.

In this article, our editorial team evaluates PQQ through that hierarchy, separating genuine promise from premature hype and showing where your money is better spent in 2026.

What Is PQQ and Why Does It Matter for Mitochondria?

Pyrroloquinoline quinone is a redox cofactor — a molecule that facilitates electron transfer in chemical reactions — found naturally in small quantities in foods like kiwifruit, parsley, green peppers, and fermented soybeans (natto). First identified in bacteria in 1979, PQQ gained mainstream supplement attention around 2010 when animal studies suggested it could stimulate mitochondrial biogenesis: the process by which cells create entirely new mitochondria.

This matters because mitochondria are the primary energy generators in every cell. As we age, mitochondrial function declines, contributing to fatigue, cognitive slowing, and increased vulnerability to oxidative stress. The idea that a single compound might trigger fresh mitochondria is genuinely exciting.

However, excitement and evidence are different things. Let's examine what the science actually supports.

The Evidence for PQQ: Cell Studies, Animal Models and Human Trials

PQQ's evidence base follows a pattern common in supplement science: strong preclinical data, but limited and small-scale human research. Understanding where each type of evidence sits is critical before spending money on any PQQ supplement.

Cell and Animal Studies (Promising but Preliminary)

In vitro (cell culture) research has consistently shown that PQQ activates PGC-1α, a master regulator of mitochondrial biogenesis. Animal studies — primarily in mice and rats — have demonstrated improvements in mitochondrial density, reduced oxidative damage, and neuroprotective effects after PQQ supplementation.

One widely cited rodent study found that PQQ-deprived mice showed impaired growth, immune dysfunction, and reproductive problems (Steinberg et al., 2003 — PubMed). These findings are genuine, but cell and animal studies have notoriously poor translation rates to human outcomes.

Human Clinical Trials (Limited and Small)

As of 2026, published human trials on PQQ remain few and generally involve small sample sizes (typically 10–40 participants). The most cited study, published in the Journal of Nutritional Biochemistry, involved 17 adults taking 20 mg of PQQ daily for 8 weeks (Harris et al., 2013 — PubMed).

Researchers observed reductions in C-reactive protein (a marker of inflammation) and improvements in some markers of mitochondrial function, but cognitive outcomes were not primary endpoints.

A Japanese trial using PQQ alongside CoQ10 reported subjective improvements in vigour and fatigue in a small cohort of middle-aged adults (Nakano et al., 2012 — PubMed). While encouraging, subjective endpoints in unblinded studies carry significant bias risk.

The honest assessment: PQQ has biological plausibility and promising preclinical data, but it lacks the robust, replicated human trial evidence that separates a speculative ingredient from a proven one.

PQQ vs Established Nootropics: An Evidence Comparison

To understand where PQQ truly sits, it helps to compare it against compounds with stronger clinical track records. This isn't about dismissing PQQ — it's about making informed decisions with your supplement budget.

The gap is clear. Citicoline has demonstrated improved attention and psychomotor speed alongside increased frontal lobe bioenergetics on MRI in controlled trials*. A 2012 systematic review in Food and Nutrition Sciences concluded that rhodiola rosea significantly reduced mental fatigue and improved short-term memory in replicated human studies* (Hung et al., 2012 — PubMed).

L-theanine combined with caffeine has improved both speed and accuracy of attention tasks versus either compound alone*. PQQ may eventually accumulate similar evidence, but in 2026, it hasn't reached that standard.

PQQ Dosage, Forms and What to Look For

If you choose to try a PQQ supplement, the practical details matter. Most commercially available products use PQQ disodium salt (BioPQQ® is the most widely studied form). Doses in human studies have ranged from 10 mg to 20 mg per day, with 20 mg being the most common in trials reporting positive biomarker changes.

PQQ is available as standalone capsules, combined with CoQ10, or occasionally as part of mitochondrial support stacks. The compound is water-soluble and appears to be absorbed reasonably well when taken with food.

Key Points When Evaluating PQQ Products

• Dose transparency: Look for products that clearly state the PQQ dose per serving (10–20 mg), not hidden in a proprietary blend.
• Form: PQQ disodium salt is the form used in most research. Check the label for this specific form.
• Third-party testing: Independent testing for purity and potency adds confidence. Look for Informed Sport or NSF certification.
• Realistic claims: Be wary of brands claiming PQQ will "reverse ageing" or "regenerate your brain." The evidence doesn't support these claims.

Who Might Benefit from PQQ — and Who Should Prioritise Elsewhere

PQQ may be worth exploring for adults who have already built a strong foundation with well-evidenced compounds and want to add an emerging ingredient. It's particularly discussed among longevity-focused individuals interested in mitochondrial health.

However, if you're experiencing brain fog, mental fatigue, or age-related cognitive changes, the evidence strongly suggests starting with compounds that have a proven track record. Phosphatidylserine (50 mg) and huperzine A (200 mcg) — both supporting acetylcholine levels and neuronal membrane health* — have a more established evidence base than PQQ currently does.

Similarly, if stress and energy crashes are your primary concern, rhodiola rosea (200 mg) has demonstrated significant, replicated results for reducing mental fatigue and supporting sustained energy*. These are ingredients where you're spending money on outcomes, not promises.

Where Evidence-First Formulation Fits In

Our editorial position on PQQ reflects a broader principle worth stating explicitly: ingredients should earn their place in a formula through replicated human evidence at clinically studied doses. This matters because the supplement industry has a well-documented pattern of rushing trending compounds to market before adequate human data exists — a point the NIH Office of Dietary Supplements has repeatedly highlighted.

Noobru Advantage applies this principle by combining L-theanine (200 mg), phosphatidylserine (50 mg), ashwagandha (120 mg), and huperzine A (200 mcg) — each with multiple human trials supporting cognitive benefits*.

For those dealing with chronic stress and energy crashes, Noobru Pro features rhodiola rosea (200 mg), acetyl L-carnitine (500 mg), and Alpha GPC (150 mg) — adaptogens and nootropics with established evidence for sustained energy without the crash*.

Both are delivered as drinkable sachets with full ingredient transparency on every label. We don't include PQQ — not because we think it's worthless, but because the human trial data isn't mature enough to include it responsibly alongside clinically validated ingredients. When that changes, we'll reassess.

Key Takeaways

• PQQ (pyrroloquinoline quinone) has promising preclinical evidence for mitochondrial biogenesis, but limited human clinical trial data as of 2026.
• Human studies have been small (typically fewer than 50 participants) and short-term, with no large-scale replicated trials confirming cognitive or energy benefits.
• Established nootropics like citicoline, rhodiola rosea, L-theanine, and phosphatidylserine have considerably stronger evidence bases for cognitive support, stress management, and sustained energy.*
• If you do try PQQ, look for PQQ disodium salt at 10–20 mg per day, with full dose transparency and third-party testing.
• Prioritising evidence-backed ingredients at clinical doses is a more reliable path to cognitive and energy benefits than chasing emerging compounds with incomplete data.

Frequently Asked Questions

What does a PQQ supplement actually do?

PQQ (pyrroloquinoline quinone) is a redox cofactor that may support mitochondrial biogenesis — the creation of new mitochondria in cells. It also acts as a potent antioxidant. However, most evidence comes from cell and animal studies, with limited large-scale human trials confirming these effects.

What is the recommended PQQ dosage?

Most human studies have used 10–20 mg of PQQ per day, with 20 mg being the most common dose in trials reporting positive biomarker changes. There is no established recommended daily intake because PQQ is not classified as an essential nutrient. Always follow the dosage on your chosen product's label and consult a healthcare provider.

Can you take PQQ and CoQ10 together?

Yes, PQQ and CoQ10 are often taken together because they target different aspects of mitochondrial function — PQQ may support the creation of new mitochondria while CoQ10 supports energy production within existing ones. No adverse interactions have been reported in studies, though evidence for synergistic benefits in humans remains limited.

Is PQQ better than established nootropics for brain health?

Not based on current evidence. Compounds like citicoline, rhodiola rosea, and phosphatidylserine have larger bodies of human clinical data supporting cognitive benefits*. PQQ shows promise in preclinical research but lacks the depth of replicated human trials these ingredients have accumulated.

Are there side effects of PQQ supplements?

PQQ appears well tolerated at doses up to 20 mg per day in short-term studies. Some users report headaches, mild digestive discomfort, or fatigue. Long-term safety data in humans is still limited, so caution is warranted.

References

1. Harris, C.B. et al. (2013). Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. Journal of Nutritional Biochemistry, 24(12), 2076–2084. PubMed 23791417
2. Nakano, M. et al. (2012). Effect of oral supplementation with pyrroloquinoline quinone on stress, fatigue, and sleep. Functional Foods in Health and Disease, 2(8), 307–324. PubMed 22293482
3. Steinberg, F.M. et al. (2003). Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. Journal of Nutrition, 133(10), 3238–3244. PubMed 12615662
4. Hung, S.K., Perry, R. & Ernst, E. (2011). The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine, 18(4), 235–244. PubMed 22643043
5. Office of Dietary Supplements — Dietary Supplement Fact Sheets. National Institutes of Health. NIH ODS
6. Examine.com (2026). Pyrroloquinoline Quinone (PQQ) — Research Analysis. Examine.com

*These statements have not been evaluated by the Food and Drug Administration or MHRA. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any supplement regimen.

Related reading

• Best Nootropics for Focus and Memory | Ginkgo Biloba Supplement Guide
• Ashwagandha Supplement: The Complete Guide to Benefits, Dosage & What to Look For
• Bacopa Monnieri Supplement: Evidence on Memory & Focus

---